FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $2.5B
1-Year Est. Return 52.94%
This Quarter Est. Return
1 Year Est. Return
+52.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.5B
AUM Growth
+$357M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$155M
2
+$19.9M
3
+$16.1M
4
ORKA
Oruka Therapeutics
ORKA
+$11.7M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$11.6M

Top Sells

1
+$24M
2
+$18.3M
3
+$16.1M
4
APLT icon
Applied Therapeutics
APLT
+$10.7M
5
PEPG icon
PepGen
PEPG
+$6.84M

Sector Composition

1 Healthcare 99.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$256M 10.27%
6,570,392
+75,000
2
$213M 8.55%
12,855,194
+628,251
3
$183M 7.33%
10,109,279
4
$180M 7.21%
988,460
5
$155M 6.23%
+5,985,347
6
$127M 5.08%
2,416,952
+45,648
7
$100M 4.03%
879,405
-160,000
8
$97.4M 3.9%
3,383,950
+69,601
9
$95.7M 3.84%
3,760,457
+127,853
10
$86.2M 3.46%
1,754,834
11
$81.7M 3.27%
8,785,284
12
$75.6M 3.03%
2,832,867
-898,200
13
$74M 2.97%
2,209,189
+43,598
14
$52.9M 2.12%
19,391,687
+3,175,471
15
$52.2M 2.09%
1,587,527
16
$46.4M 1.86%
1,044,154
+172,180
17
$45.2M 1.81%
997,455
18
$44.2M 1.77%
875,667
19
$42.7M 1.71%
3,687,867
20
$42.5M 1.7%
4,142,855
21
$35.2M 1.41%
633,715
+208,715
22
$34.6M 1.39%
8,157,385
23
$29.1M 1.16%
770,000
24
$27.4M 1.1%
1,485,630
-75,600
25
$24.7M 0.99%
7,381,090
1
2 3